Sater and his team are finding that applying different anti-PD-L1 antibody clones to the same type of tumour tissue can produce different staining patterns. “Non-specificity can be a big problem ...

This study demonstrated that the inflammatory response in a subset of anal, penile, and vulvar HSILs was associated with ...

HSILs also exhibited higher PD-L1 expression (padj < 0.01 and < 0.01 for the SP142 and 22C3 clones, respectively), based on the Poisson generalized linear model.” These findings suggest that HPV ...

To unlock the further potential of PD-L1 clones, Abcam has developed a range of proprietary and licensed PD-L1 clones available to both diagnostic and academic scientists to help identify those ...

During a live event, Matthew Galsky, MD, discussed adjuvant nivolumab in muscle-invasive bladder cancer and the benefit in ...

Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

The PFS benefit was demonstrated in patients with either PD-L1-positive or PD-L1-negative tumors. Akeso noted that no new safety signals were identified in this Phase III study. The full data set ...